Form 4: BIOLIFE CTO Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


BIOLIFE SOLUTIONS INC's Chief Technology Officer, Sean Werner, disposed of 1,681 shares of common stock to cover tax withholding obligations.

Summary

  • Sean Werner, Chief Technology Officer of BIOLIFE SOLUTIONS INC (BLFS), reported a transaction involving the disposition of common stock.
  • The transaction occurred on March 19, 2026, and was filed on March 23, 2026.
  • A total of 1,681 shares of common stock were withheld by the Issuer to satisfy tax withholding obligations of the reporting person.
  • These obligations arose upon the release of restricted stock units.
  • The shares were disposed of at a price of $19.12 per share.
  • Following this transaction, Sean Werner beneficially owns 48,251 shares of BIOLIFE SOLUTIONS INC common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It's a routine compliance filing for tax withholding on equity compensation, not indicative of operational performance or strategic shifts.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to tax withholdings from equity compensation, are common occurrences in publicly traded companies. These transactions are typically routine and do not necessarily reflect a change in management's confidence in the company's future prospects, unlike open market sales.

Stakeholder Impact

  • Minimal direct impact on shareholders as this is a routine, non-discretionary transaction for tax purposes.
  • No direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
03/19/2026Transaction Date: Disposition of shares for tax withholding.
03/23/2026Filing Date of Form 4.

Recommendation

hold

This Form 4 filing details a routine, non-discretionary sale of shares by an executive to cover tax obligations related to equity compensation. It does not provide new information regarding the company's operational performance, financial health, or strategic direction. Therefore, it does not warrant a change in investment thesis, and a 'hold' recommendation is maintained based solely on this filing.

Keywords

BIOLIFE SOLUTIONS, BLFS, Sean Werner, Chief Technology Officer, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.